Conventional Treatments
for Neuropathy

Health Interests

Common Neuropathy Medications & Neurologist Treatments

This chart separates symptom-control treatments from cause-directed treatments. Most common prescribed drugs for painful neuropathy reduce pain; they usually do not regenerate or reverse nerve damage by themselves.

Treatment Type How it helps Commonly used by neurologists for Reverse neuropathy? Evidence snapshot Source link
Gabapentin Medication Calms overactive pain signaling in neuropathic pain. Painful diabetic neuropathy and other peripheral neuropathic pain. No Guidelines list gabapentinoids among first-line options for neuropathic pain and painful diabetic neuropathy. PMC review
AAN guideline
Pregabalin Medication Reduces abnormal nerve firing and lowers pain intensity. Painful diabetic neuropathy and generalized neuropathic pain. No Recommended as a first-line class option in multiple guidelines; ADA named pregabalin as an initial approach for diabetic neuropathic pain. PMC review
PDPN review
Duloxetine Medication Raises serotonin and norepinephrine signaling that dampens pain pathways. Painful diabetic neuropathy and other neuropathic pain syndromes. No SNRIs are first-line for neuropathic pain; duloxetine is an initial option for diabetic neuropathic pain. PMC review
PDPN review
Venlafaxine Medication SNRI that can reduce neuropathic pain signaling. Used when an SNRI approach is chosen and duloxetine is not the fit. No Guidelines include SNRIs such as venlafaxine as effective first-line options. PMC review
Amitriptyline / other TCAs Medication Modulates central pain pathways and can reduce burning, shooting, or tingling pain. Painful neuropathy when TCA risks are acceptable. No TCAs are a first-line medication class in neuropathic pain guidance and AAN PDN recommendations. PMC review
AAN guideline
Lidocaine 5% patch Topical Numbs localized painful skin areas and reduces peripheral pain signaling. Focal peripheral neuropathic pain. No Algorithms list topical lidocaine for focal neuropathic pain, usually after or alongside oral class options. Treatment algorithm
AAN guideline
Capsaicin patch Topical Defunctionalizes pain fibers locally, which can reduce focal neuropathic pain. Focal peripheral neuropathic pain. No Commonly listed as a later-line or focal-treatment option in neuropathic pain algorithms. Treatment algorithm
Switching to another effective class Neurologist strategy If one class fails or causes side effects, moving to a different class can still reduce pain. Painful diabetic neuropathy and other neuropathic pain when first attempt fails. No AAN recommends trying a different effective medication class rather than persisting with an ineffective one. AAN summary
Strict glucose control Cause-directed Treats the driver of diabetic nerve injury and can improve symptoms or slow progression. Diabetic neuropathy or treatment-induced neuropathy contexts. Sometimes Treatment-induced diabetic neuropathy showed substantial improvement after 18 months of glycemic control; early diabetic neuropathy may stabilize or improve. Reversible TIND study
IVIG Cause-directed Modifies autoimmune attack on nerves. CIDP and some autoimmune neuropathies. Sometimes NINDS says IVIG is a common treatment for autoantibody-related neuropathy; CIDP guidelines strongly recommend IVIG as initial treatment. NINDS
CIDP guideline summary
Corticosteroids Cause-directed Suppresses inflammatory or autoimmune nerve injury. CIDP and inflammatory neuropathies. Sometimes NINDS notes some inflammatory or autoimmune neuropathies improve with steroids; CIDP guidelines strongly recommend corticosteroids as initial treatment. NINDS
CIDP guideline summary
Plasma exchange Cause-directed Removes harmful circulating antibodies contributing to neuropathy. CIDP when IVIG or steroids are ineffective or not suitable. Sometimes CIDP guidelines strongly recommend plasma exchange if IVIG and corticosteroids are ineffective. CIDP guideline summary
Carpal tunnel decompression Procedure Relieves mechanical compression of the median nerve. Entrapment neuropathy such as carpal tunnel syndrome. Can improve if compression is the cause AAFP reports lasting good outcomes in 70% to 90% of carpal tunnel decompression cases. AAFP guideline
Most common prescribed meds
Gabapentin, pregabalin, duloxetine, venlafaxine, and amitriptyline/other TCAs are the main evidence-based classes repeatedly named as first-line treatments for painful neuropathy.
What neurologists commonly do
Neurologists usually separate symptom control from cause treatment: pain medicines for painful neuropathy, and cause-directed therapy such as glucose control, IVIG, steroids, plasma exchange, or decompression when the neuropathy has a treatable cause.
Bottom line on reversal
Most pain medicines do not reverse neuropathy. Reversal or meaningful recovery is mainly possible when the cause is removed or treated early, such as autoimmune, compression, medication-induced, or some early diabetic cases.

Direct sources

Neuropathic pain review https://pmc.ncbi.nlm.nih.gov/articles/PMC5685445/
AAN painful diabetic polyneuropathy guideline https://www.neurology.org/doi/10.1212/WNL.0000000000013038
AAN clinician summary https://www.aan.com/Guidelines/home/GuidelineDetail/1037
Painful diabetic peripheral neuropathy review https://pmc.ncbi.nlm.nih.gov/articles/PMC10243347/
Neuropathic pain treatment algorithm https://pmc.ncbi.nlm.nih.gov/articles/PMC6544553/
NINDS peripheral neuropathy https://www.ninds.nih.gov/health-information/disorders/peripheral-neuropathy
Treatment-induced diabetic neuropathy study https://pmc.ncbi.nlm.nih.gov/articles/PMC3057039/
Carpal tunnel guideline https://www.aafp.org/pubs/afp/issues/2016/1215/p993.html
Added clickable direct source links in each row plus a full source block for website visitors who want the original clinical review or guideline.

Watch The Full Explanation